Stopped: Funding not received
This study is an investigation of a behavioral speech and language treatment for emotional prosody recognition and production deficits in subacute right hemisphere stroke.
Age range
18 Years – 89 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in accuracy on affective prosody expression following aprosodia intervention compared to spontaneous recovery
Timeframe: Baseline, 1 week after Phase I Intervention, 1 week after Phase II Intervention
Change in accuracy on affective prosody recognition following aprosodia intervention compared to spontaneous recovery
Timeframe: Baseline, 1 week after Phase I Intervention, 1 week after Phase II Intervention
Change in accuracy on standardized contextual measures of affective prosody expression
Timeframe: Baseline, 1 week after Phase I Intervention, 1 week after Phase II Intervention
Change in accuracy on standardized contextualized measures of affective prosody recognition
Timeframe: 1 week after Phase I Intervention, 1 week after Phase II Intervention
Change in resting state functional connectivity
Timeframe: Baseline, 1 week after Phase I Intervention, 1 week after Phase II Intervention
Behavioral and neurological predictors of aprosodia intervention outcomes
Timeframe: Baseline, 1 week after Phase I or Phase II Intervention